New Delhi: Shopper care main Haleon, has introduced plans to make investments round Rs 2000 crore (£175 million) to set up its first manufacturing facility in India.
The proposed greenfield facility will come up on a 40-acre website in Pithampur, Madhya Pradesh, and is predicted to be operational by 2029–30.
It can function automated manufacturing capabilities and is projected to create up to 500 jobs, together with oblique employment alternatives,
Amid rising demand, the maker of Sensodyne toothpaste is investing in the brand new facility to strengthen its provide community throughout India and different Asian markets.
“India is a key strategic marketplace for Haleon and an necessary driver of our long-term development. This funding strengthens our native manufacturing footprint and expands our attain in one of many world’s fastest-growing shopper well being markets,” mentioned Brian McNamara, CEO, Haleon.
Haleon operates in greater than 170 markets and posted complete income of $14 billion (at present change fee) in 2025
The NYSE-listed firm was spun off from GSK in 2022, changing into an unbiased enterprise fashioned by the merger of US pharma big Pfizer and GSK’s shopper healthcare division.
Source link
#Haleon #set #manufacturing #facility
